Media mentions

<p>Roger Gomis, head of the Growth Control and Cancer Metastasis Lab at IRB Barcelona and founder of Inbiomotion.</p>
15 Oct 2019

Inbiomotion unravelling the enigma of breast cancer

The economics newspaper Expansión Catalunya has echoed the forthcoming publication of the results of a clinical assay of the MAF-Test, a diagnostic test for breast cancer patients developed by Inbiomotion, a spin-off from IRB Barcelona set up in 2010 by the researcher Roger Gomis. The results are expected to be out in November.

<p>The researcher Meritxell Teixidó has been interviewed on the TVE2’s documentary ¡Qué animal!</p>
15 Oct 2019

Peptides in bee and scorpion venoms for drug delivery to the brain

Meritxell Teixidó, a researcher at IRB Barcelona, has been interviewed on the TVE2’s documentary ¡Qué animal! about her work with peptides from scorpion and bee venom in search of drugs that can reach the brain. "These poisons are able to reach the brain, which explains their toxicity.

<p>The director general of BIST, Gabby Silberman, and the directors of the seven BIST centers planted a tree at the entrance of the BIST headquarters as a symbolic gesture with which the institution joins the global mobilizations against the climate crisis.</p>
01 Oct 2019

Scientists warn that continued climatic change will be"catastrophic" and cause "devastation”

The radio station COPE and the newspapers La Vanguardia and La Razón, among others, have reported on the statement of 7 BIST centres, among them IRB Barcelona, in favour of global action against the climate crisis.


Office of Communications and External Relations
Tel: +34 93 40 34569

Basic information about IRB

Quick facts

IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.

IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.

The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.

Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.

Our Board of Trustees comprises members of the Catalan Government (from the Department of Economy and Competitivity and the Department of Health), the University of Barcelona, a representative from the BBVA Foundation as well as internationally renowned scientists.